Bgf Business Growth Fund
BGF publicly describes minority equity investment, sometimes combined with debt, patient capital without fixed exit deadlines, and support for business scaling.
BGF focuses on UK- and Ireland-headquartered businesses.
Its Growth Stage criteria include typically £1m-£10m profit or £3m+ ARR for technology companies, an initial BGF investment of £3m-£30m, and a strong track record and growth strategy. BGF also describes an Early Stage route for late-seed to Series B life-sciences or deep-tech businesses seeking £3m-£10m.[1][2][3][4][7]
What does Bgf Business Growth Fund invest in?
BGF is the trading brand associated with Business Growth Fund Limited and the wider BGF Group. Business Growth Fund Limited is an active private limited company registered in England and Wales, with a stated SIC activity covering venture and development capital companies.
BGF publicly describes minority equity investment, sometimes combined with debt, follow-on funding and patient capital without fixed exit deadlines. It also describes support in scaling businesses.[1][2]
For Growth Stage businesses, BGF states that initial funding is generally £3m-£30m, with significant follow-on funding for product development, international expansion, strategic acquisitions, partnerships and other growth strategies.
BGF states that it is a minority equity investor and does not take control. It describes its capital as patient, with exit timeframes intended to maximise valuation and outcomes for shareholders.[3][4]
Owners comparing capital alternatives can review Auxo’s capital advisory services, valuation services, and full-versus-partial sale framework.
What should a business owner evaluate before taking capital from Bgf Business Growth Fund?
For an owner considering a sale, minority recapitalisation or growth investment, BGF’s published model is non-control minority investment with patient capital, regional coverage across the UK and Ireland, and stated follow-on funding. The proposed security, governance rights, dilution, follow-on funding expectations, exit planning, valuation methodology, fees and investing legal entity should be established for the specific proposal.
The cited How it Works page describes an initial meeting, information sharing, heads of terms, third-party due diligence and deal completion. BGF identifies BGF Investment Management Limited as an FCA-authorised and regulated group member; that regulatory statement applies to that entity rather than automatically to every BGF group entity.[2][3][4][11]
Will the investment be ordinary equity, preferred equity, debt or a combination
What investment criteria does Bgf Business Growth Fund publicly describe?
BGF’s Growth Stage criteria include a strong track record and growth strategy, typically £1m-£10m profit or £3m+ ARR for technology companies, private ownership, UK or Ireland headquarters, and an initial BGF investment of £3m-£30m. The criteria also state that the business should not be a financial institution.
BGF separately describes an Early Stage route for late-seed to Series B businesses with innovation in life sciences or deep tech and IP protection, seeking £3m-£10m from BGF or £5m-£30m in total funding.[2][3]
The published criteria distinguish between Growth Stage and Early Stage opportunities. Growth Stage criteria refer to a strong track record and growth strategy, typically £1m-£10m profit or £3m+ ARR for technology companies, and an initial BGF investment of £3m-£30m. Early Stage criteria refer to late seed to Series B, IP-protected life-sciences or deep-tech businesses, and BGF funding of £3m-£10m.[2]
BGF’s Growth Stage funding criteria require the business to be headquartered in the UK or Ireland. BGF lists regional offices in Aberdeen, Belfast, Birmingham, Bristol, Cambridge, Cardiff, Cork, Dublin, Edinburgh, Leeds, London, Manchester, Newcastle, Nottingham and Reading.[3][6]
BGF states that it has backed more than 600 growing businesses across the UK and Ireland. Its portfolio records include current and exited companies, together with sector, region, investment stage, investment date and status fields.
Recent public exits include Strathberry on 8 September 2026, following an initial £8 million investment in 2022; bf1systems on 19 August 2026, following a £2.4 million investment in June 2019; Mortgage Support Services on 20 August 2026, following a partnership that began in 2015; and Walker Precision Engineering on 20 July 2026, following a minority investment in 2017.[5][7][8][9][10]
BGF’s 2026 newsroom announcements include investments or financings involving Redfaire, TidalSense, Black Cat, Mach42, Urban Zoo, Everflow, Rappor, Luffy AI, Gaussion, TRIMTECH Therapeutics, CroíValve and Wild Frontiers. The newsroom also records the 2026 exits from Strathberry, bf1systems, Mortgage Support Services and Walker Precision Engineering.[7][8][9][10]
What is not clear from Bgf Business Growth Fund's public materials?
The cited BGF How it Works page describes the investment process, heads of terms, due diligence and application information but does not publish a universal management-fee schedule, carried-interest schedule, minimum fee, tail period or standard ownership-percentage formula.
The cited Strathberry exit announcement discloses the initial £8 million investment and revenue growth but does not disclose the exit consideration, financing structure, detailed ownership percentage or transaction-fee terms.[2][7]
Questions to ask before taking capital from Bgf Business Growth Fund
Which BGF legal entity will invest, and which entity will manage the investment?
What percentage ownership, board rights, veto rights, information rights and reserved matters are proposed?
Will the investment be ordinary equity, preferred equity, debt or a combination?
What fees, expenses, carry or performance economics, minimum fees and tail obligations would apply?
Is follow-on funding discretionary or committed under the proposed structure?
What ownership horizon and exit options or timing assumptions does BGF expect?
How would future acquisitions, founder liquidity, succession and management incentives be handled?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Investment strategy
- Investment approach
- Industry / market focus
- Geography / market coverage
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.